Research - Genoa, Liguria, Italy
Integrata is a European Training Network (ETN) funded in the framework of the H2020 Marie Skłodowska- Curie ITN programme. The INTEGRATA network aims at the education of promising Early Stage Researchers (ESRs) who will learn the key steps of the modern discovery process of new drugs and therapeutic approaches (i.e. enzyme inhibition measurements, toxicities on cell cultures, preliminary pharmacological parameters, and in vivo PoC studies), focusing specifically on NAD production and on NAD/nucleotide signaling as targets for the development of new cancer therapeutics.The project is based on a profound interaction between the academic and industrial sectors, encompassing academic institutions, research centres, and SMEs, all with proven experience in higher education and training and geared with state-of-the art scientific and technical expertise and infrastructures. By combining the beneficiaries' expertise in cancer research, medicinal chemistry, biochemistry, drug design, mAb manufacture, purification and characterization, as well as clinical haematology and oncology, together with experience in project management, INTEGRATA will create a multidisciplinary environment, where fourteen ESRs will exploit the tremendous potential of NAD-producing enzymes and of NAD/nucleotide-signaling as targets for treating cancer.This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 813284Links:Facebook: https://www.facebook.com/Integrata-100818534671136/Twitter: https://twitter.com/integrata?s=08
ASP.NET
Microsoft-IIS
Google Font API
Mobile Friendly